financetom
Business
financetom
/
Business
/
Form 8.3
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Form 8.3
Nov 13, 2025 7:40 AM

LONDON--(BUSINESS WIRE)--

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

 

Millennium International Management LP

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

 

American Axle & Manufacturing Holdings, Inc.

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

 

12th November 2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

 

Yes, Dowlais Group plc

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

 

USD 0.01 common (US0240611030)

 

 

 

Interests

 

Short positions

 

Number

 

%

 

Number

 

%

(1) Relevant securities owned and/or controlled:

 

3,483,502

 

2.935%

 

638,098

 

0.538%

(2) Cash-settled derivatives:

 

-

 

-

 

4,418,270

 

3.722%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

-

 

-

 

-

 

-

TOTAL:

 

3,483,502

 

2.935%

 

5,056,368

 

4.260%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

 

 

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit (USD)

US0240611030

Purchase

307

6.49

US0240611030

Purchase

38

6.35

US0240611030

Purchase

7

6.44

US0240611030

Purchase

318

6.43

US0240611030

Sale

1,000

6.43

US0240611030

Purchase

2

6.48

US0240611030

Purchase

170

6.37

US0240611030

Purchase

238

6.36

US0240611030

Sale

1,520

6.36

US0240611030

Purchase

397

6.41

US0240611030

Purchase

28

6.38

US0240611030

Purchase

117

6.52

US0240611030

Sale

200

6.52

US0240611030

Purchase

55

6.42

US0240611030

Sale

1,000

6.42

US0240611030

Purchase

207

6.54

US0240611030

Purchase

188

6.51

US0240611030

Sale

1,700

6.51

US0240611030

Purchase

543

6.46

US0240611030

Sale

2,000

6.46

US0240611030

Purchase

274

6.47

US0240611030

Purchase

8

6.50

US0240611030

Sale

105

6.50

US0240611030

Purchase

32

6.45

US0240611030

Purchase

230

6.39

US0240611030

Purchase

817

6.40

US0240611030

Sale

480

6.40

US0240611030

Purchase

21

6.55

US0240611030

Purchase

522

6.49

US0240611030

Sale

57,667

6.49

US0240611030

Purchase

8,332

6.35

US0240611030

Purchase

15,068

6.44

US0240611030

Purchase

263

6.30

US0240611030

Purchase

1,580

6.34

US0240611030

Purchase

2,967

6.43

US0240611030

Purchase

1,200

6.37

US0240611030

Purchase

4,312

6.36

US0240611030

Purchase

651

6.41

US0240611030

Purchase

1,679

6.38

US0240611030

Purchase

210

6.42

US0240611030

Purchase

272

6.51

US0240611030

Purchase

1,147

6.50

US0240611030

Purchase

457

6.53

US0240611030

Purchase

677

6.45

US0240611030

Sale

677

6.45

US0240611030

Purchase

978

6.39

US0240611030

Purchase

500

6.31

US0240611030

Purchase

100

6.40

US0240611030

Purchase

100

6.32

US0240611030

Purchase

800

6.33

US0240611030

Purchase

15,273

6.49

US0240611030

Purchase

792

6.35

US0240611030

Sale

742

6.35

US0240611030

Purchase

160

6.30

US0240611030

Sale

10

6.34

US0240611030

Purchase

23,214

6.48

US0240611030

Purchase

18,107

6.37

US0240611030

Sale

4

6.37

US0240611030

Purchase

404

6.36

US0240611030

Purchase

42

6.29

US0240611030

Purchase

1,900

6.41

US0240611030

Purchase

3,181

6.38

US0240611030

Purchase

3,250

6.52

US0240611030

Purchase

340

6.42

US0240611030

Purchase

1,400

6.54

US0240611030

Purchase

1,748

6.51

US0240611030

Purchase

100

6.46

US0240611030

Purchase

3,831

6.47

US0240611030

Purchase

100

6.50

US0240611030

Purchase

5,212

6.53

US0240611030

Purchase

1,330

6.39

US0240611030

Purchase

100

6.31

US0240611030

Purchase

600

6.40

US0240611030

Purchase

101

6.32

US0240611030

Sale

4

6.32

US0240611030

Purchase

5,034

6.55

US0240611030

Sale

100

6.33

US0240611030

Purchase

6,234

6.49

US0240611030

Sale

100

6.49

US0240611030

Purchase

4

6.35

US0240611030

Sale

118

6.35

US0240611030

Sale

15,138

6.44

US0240611030

Purchase

313

6.43

US0240611030

Purchase

8,040

6.48

US0240611030

Sale

471

6.48

US0240611030

Purchase

54

6.37

US0240611030

Purchase

778

6.36

US0240611030

Sale

14

6.36

US0240611030

Purchase

200

6.41

US0240611030

Sale

124

6.41

US0240611030

Purchase

100

6.38

US0240611030

Sale

7

6.38

US0240611030

Purchase

100

6.42

US0240611030

Sale

7

6.42

US0240611030

Sale

51

6.54

US0240611030

Purchase

1

6.51

US0240611030

Sale

927

6.51

US0240611030

Sale

543

6.46

US0240611030

Purchase

410

6.47

US0240611030

Sale

264

6.47

US0240611030

Purchase

100

6.50

US0240611030

Purchase

2,700

6.53

US0240611030

Purchase

14

6.45

US0240611030

Sale

14

6.39

US0240611030

Purchase

100

6.28

US0240611030

Sale

152

6.31

US0240611030

Purchase

155

6.32

US0240611030

Sale

172

6.32

US0240611030

Sale

5,396

6.49

US0240611030

Purchase

4,461

6.35

US0240611030

Sale

6

6.35

US0240611030

Purchase

10,912

6.30

US0240611030

Purchase

365

6.34

US0240611030

Purchase

471

6.48

US0240611030

Sale

254

6.48

US0240611030

Purchase

1,501

6.37

US0240611030

Purchase

20,431

6.36

US0240611030

Sale

120

6.36

US0240611030

Purchase

600

6.41

US0240611030

Purchase

6,107

6.38

US0240611030

Sale

562

6.38

US0240611030

Purchase

400

6.52

US0240611030

Purchase

19

6.54

US0240611030

Sale

3,664

6.54

US0240611030

Purchase

260

6.51

US0240611030

Sale

148

6.51

US0240611030

Sale

45

6.46

US0240611030

Sale

5,088

6.47

US0240611030

Sale

308

6.50

US0240611030

Purchase

682

6.45

US0240611030

Sale

682

6.45

US0240611030

Purchase

396

6.39

US0240611030

Purchase

1,852

6.31

US0240611030

Purchase

29,783

6.32

US0240611030

Purchase

7,000

6.33

US0240611030

Purchase

1,874

6.49

US0240611030

Sale

26,562

6.44

US0240611030

Purchase

76

6.30

US0240611030

Sale

180

6.34

US0240611030

Sale

2,608

6.43

US0240611030

Sale

4,639

6.48

US0240611030

Purchase

3

6.37

US0240611030

Sale

148

6.52

US0240611030

Sale

375

6.42

US0240611030

Sale

760

6.54

(b) Cash-settled derivative transactions

Class of relevant security

 

Product description

e.g. CFD

 

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

 

Number of reference securities

 

Price per unit

 

US0240611030

 

Equity Swap

 

Increasing a Short Position

 

85,000

 

4.78 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

 

Product description e.g. call option

 

Writing, purchasing, selling, varying etc.

 

Number of securities to which option relates

 

Exercise price per unit

 

Type

e.g. American, European etc.

 

Expiry date

 

Option money paid/ received per unit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(ii) Exercise

Class of relevant security

 

Product description

e.g. call option

 

Exercising/ exercised against

 

Number of securities

 

Exercise price per unit

 

 

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

Class of relevant security

 

Nature of dealing

e.g. subscription, conversion

 

Details

 

Price per unit (if applicable)

 

 

 

 

 

 

 

 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

NONE

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

NONE

 

(c) Attachments

Class of relevant security:

 

USD 0.01 common (US0240611030)

 

 

 

Interests

 

Short positions

 

Number

 

%

 

Number

 

%

(1) Relevant securities owned and/or controlled:

 

3,483,502

 

2.935%

 

638,098

 

0.538%

(2) Cash-settled derivatives:

 

-

 

-

 

4,418,270

 

3.722%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

-

 

-

 

-

 

-

TOTAL:

 

3,483,502

 

2.935%

 

5,056,368

 

4.260%

0

Class of relevant security:

 

USD 0.01 common (US0240611030)

 

 

 

Interests

 

Short positions

 

Number

 

%

 

Number

 

%

(1) Relevant securities owned and/or controlled:

 

3,483,502

 

2.935%

 

638,098

 

0.538%

(2) Cash-settled derivatives:

 

-

 

-

 

4,418,270

 

3.722%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

-

 

-

 

-

 

-

TOTAL:

 

3,483,502

 

2.935%

 

5,056,368

 

4.260%

1

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected]. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Source: Millennium Partners, L.P.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Terex Shares Fall After Q3 Revenue Miss
Update: Terex Shares Fall After Q3 Revenue Miss
Oct 30, 2025
01:26 PM EDT, 10/30/2025 (MT Newswires) -- (Updates with recent stock price movement in the headline and first paragraph.) Terex ( TEX ) shares were down roughly 17% in recent Thursday trading after Q3 revenue missed analysts' estimates. The company earlier posted Q3 adjusted earnings of $1.50 per diluted share, up from $1.46 a year earlier. Analysts polled by FactSet...
--Metsera Had Talks With Bristol-Myers Prior to Pfizer, Novo Nordisk Bids, The Wall Street Journal Reports
--Metsera Had Talks With Bristol-Myers Prior to Pfizer, Novo Nordisk Bids, The Wall Street Journal Reports
Oct 30, 2025
01:20 PM EDT, 10/30/2025 (MT Newswires) -- Price: 44.65, Change: +2.05, Percent Change: +4.80 ...
EU tech chief Virkkunen to meet chipmaker Nexperia amid supply worries
EU tech chief Virkkunen to meet chipmaker Nexperia amid supply worries
Oct 30, 2025
BRUSSELS, Oct 30 (Reuters) - EU tech chief Henna Virkkunen will meet chipmaker Nexperia on Friday, she said on X, amid concerns about a deepening supply squeeze linked to the Dutch company. Tomorrow meeting @Nexperia. Important lessons being drawn for our #ChipsAct 2.0 foreseen beginning of 2026, Virkkunen said on X. She had hosted virtual meetings with the CEOs of...
Market Chatter: Metsera Had Talks With Bristol-Myers Prior to Pfizer, Novo Nordisk Bids
Market Chatter: Metsera Had Talks With Bristol-Myers Prior to Pfizer, Novo Nordisk Bids
Oct 30, 2025
01:25 PM EDT, 10/30/2025 (MT Newswires) -- Metsera (MTSR) entered into exclusive talks with Bristol-Myers Squibb ( BMY ) prior to the deal it reached with Pfizer ( PFE ) in September and Thursday's bid by Novo Nordisk ( NVO ), The Wall Street Journal reported Thursday, citing people familiar with the matter. Metsera and Bristol-Myers Squibb ( BMY )...
Copyright 2023-2026 - www.financetom.com All Rights Reserved